Mutant Huntingtin reduces HSP70 expression through the sequestration of NF‐Y transcription factor

[1]  S. Warren,et al.  Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration , 2007, Nature Neuroscience.

[2]  Mauro Delorenzi,et al.  Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. , 2007, Human molecular genetics.

[3]  I. Kanazawa,et al.  The Induction Levels of Heat Shock Protein 70 Differentiate the Vulnerabilities to Mutant Huntingtin among Neuronal Subtypes , 2007, The Journal of Neuroscience.

[4]  S. Hersch,et al.  Sp1 Is Up-regulated in Cellular and Transgenic Models of Huntington Disease, and Its Reduction Is Neuroprotective* , 2006, Journal of Biological Chemistry.

[5]  A. Suzuki,et al.  Lgl mediates apical domain disassembly by suppressing the PAR-3-aPKC-PAR-6 complex to orient apical membrane polarity , 2006, Journal of Cell Science.

[6]  M. MacDonald,et al.  Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease , 2006, Neurobiology of Disease.

[7]  Richard I. Morimoto,et al.  Progressive Disruption of Cellular Protein Folding in Models of Polyglutamine Diseases , 2006, Science.

[8]  R. Morimoto,et al.  Huntingtin and Mutant SOD1 Form Aggregate Structures with Distinct Molecular Properties in Human Cells* , 2006, Journal of Biological Chemistry.

[9]  Y. Kitaura,et al.  Active HSF1 Significantly Suppresses Polyglutamine Aggregate Formation in Cellular and Mouse Models* , 2005, Journal of Biological Chemistry.

[10]  S. Salzberg,et al.  The Transcriptional Landscape of the Mammalian Genome , 2005, Science.

[11]  S. Snyder,et al.  p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.

[12]  N. Nukina,et al.  Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine‐EGFP fluorescent aggregates , 2005, Journal of neurochemistry.

[13]  M. Mayer,et al.  Hsp70 chaperones: Cellular functions and molecular mechanism , 2005, Cellular and Molecular Life Sciences.

[14]  Mehmet Sarikaya,et al.  Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer , 2004, Nature Structural &Molecular Biology.

[15]  G. Bates,et al.  Huntingtin and the molecular pathogenesis of Huntington's disease , 2004, EMBO reports.

[16]  Y. Kuroiwa,et al.  Identification of ubiquitin‐interacting proteins in purified polyglutamine aggregates , 2004, FEBS letters.

[17]  Peter Breuer,et al.  Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. , 2004, Molecular cell.

[18]  G. Bates,et al.  Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. , 2004, Human molecular genetics.

[19]  Xiao-Jiang Li,et al.  Huntingtin-protein interactions and the pathogenesis of Huntington's disease. , 2004, Trends in genetics : TIG.

[20]  F. Hartl,et al.  Roles of molecular chaperones in protein misfolding diseases. , 2004, Seminars in cell & developmental biology.

[21]  K. Hoyt,et al.  CRE-Mediated Transcription Is Increased in Huntington's Disease Transgenic Mice , 2004, The Journal of Neuroscience.

[22]  H. Lehrach,et al.  Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin , 2003, Journal of Biological Chemistry.

[23]  Erich E Wanker,et al.  The hunt for huntingtin function: interaction partners tell many different stories. , 2003, Trends in biochemical sciences.

[24]  K. Merienne,et al.  Polyglutamine Expansion Induces a Protein-damaging Stress Connecting Heat Shock Protein 70 to the JNK Pathway* , 2003, The Journal of Biological Chemistry.

[25]  D. Rubinsztein,et al.  Transcriptional abnormalities in Huntington disease. , 2003, Trends in genetics : TIG.

[26]  M. MacDonald,et al.  Insoluble TATA-binding protein accumulation in Huntington's disease cortex. , 2002, Brain research. Molecular brain research.

[27]  F. Hartl,et al.  Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Olson,et al.  Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. , 2002, Human molecular genetics.

[29]  Charles Kooperberg,et al.  Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain. , 2002, Human molecular genetics.

[30]  R. Morimoto,et al.  Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. , 2002, Journal of cell science.

[31]  Dimitri Krainc,et al.  Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease , 2002, Science.

[32]  Zhao-Xue Yu,et al.  Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. , 2002, Human molecular genetics.

[33]  He Li,et al.  Interaction of Huntington Disease Protein with Transcriptional Activator Sp1 , 2002, Molecular and Cellular Biology.

[34]  Shihua Li,et al.  Chaperone Suppression of Cellular Toxicity of Huntingtin Is Independent of Polyglutamine Aggregation* , 2001, The Journal of Biological Chemistry.

[35]  R. Mantovani,et al.  HSP-CBF Is an NF-Y-dependent Coactivator of the Heat Shock Promoters CCAAT Boxes* , 2001, The Journal of Biological Chemistry.

[36]  F. Gage,et al.  Identities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression , 2001, The Journal of cell biology.

[37]  C A Ross,et al.  Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity , 2001, Science.

[38]  M. Hayden,et al.  The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Paulson,et al.  Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. , 2000, Human molecular genetics.

[40]  J. Cha,et al.  Transcriptional dysregulation in Huntington’s disease , 2000, Trends in Neurosciences.

[41]  N. Nukina,et al.  Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. , 2000, Human molecular genetics.

[42]  I. Kanazawa,et al.  Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. , 2000, Human molecular genetics.

[43]  E. Wanker,et al.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Housman,et al.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Benzer,et al.  Genetic suppression of polyglutamine toxicity in Drosophila. , 2000, Science.

[46]  R. Mantovani,et al.  The molecular biology of the CCAAT-binding factor NF-Y. , 1999, Gene.

[47]  A. Wolffe,et al.  Xenopus NF‐Y pre‐sets chromatin to potentiate p300 and acetylation‐responsive transcription from the Xenopus hsp70 promoter in vivo , 1998, The EMBO journal.

[48]  B. Crombrugghe,et al.  Role of the CCAAT-binding protein CBF/NF-Y in transcription. , 1998, Trends in biochemical sciences.

[49]  K. Ohtsuka,et al.  Characterization of HSE sequences in human Hsp40 gene: structural and promoter analysis. , 1998, Biochimica et biophysica acta.

[50]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[51]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[52]  M. Fiorenza,et al.  Developmental activation of an episomic hsp70 gene promoter in two-cell mouse embryos by transcription factor Sp1. , 1997, Nucleic acids research.

[53]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[54]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[55]  W. D. Morgan,et al.  Transcription factor Sp1 binds to and activates a human hsp70 gene promoter , 1989, Molecular and cellular biology.

[56]  R. Morimoto,et al.  Coordinate changes in heat shock element-binding activity and HSP70 gene transcription rates in human cells. , 1988, Molecular and cellular biology.

[57]  R. Kingston,et al.  Multiple basal elements of a human hsp70 promoter function differently in human and rodent cell lines , 1987, Molecular and cellular biology.

[58]  R. Tjian,et al.  Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with a human hsp70 gene promoter , 1987, Molecular and cellular biology.

[59]  R. Kingston,et al.  Human HSP70 promoter contains at least two distinct regulatory domains. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[60]  I. Guzhova,et al.  Hsp70 chaperone as a survival factor in cell pathology. , 2006, International review of cytology.